Statins May Lower Glioma Risk Over Time

New research indicates long-term use of statin may reduce the risk of brain and spine tumors, called glioma.

(Wikipedia: a glioma is a type of tumor that starts in the brain or spine. It is called a glioma because it arises from glial cells. The most common site of gliomas is the brain. Gliomas make up ~30% of all brain and central nervous system tumors and 80% of all malignant brain tumors.)

A case-control (observational, not random control trial) study of Danes showed that the risk of glioma was lower among long-term statin users as compared to non-users. Long-term user was defined in this study as 5+ years. The clearest correlation was for men aged 60+. Women under 60 years was lower, but not for women 60+.

The study was supported by the Danish Cancer Society and University of Southern Denmark. The authors were independent from the funding sources.

Suzanne B. Robotti

Suzanne Robotti founded MedShadow Foundation in 2012. Learn more about Su and her mission.

Did you find this article helpful?

Notify of
Inline Feedbacks
View all comments

Latest News

Covid-19: Side Effects of Trump’s Treatments

Covid-19: Side Effects of Trump’s Treatments

President Donald Trump announced (via Twitter, of course) what some considered unthinkable, and others considered inevitable — that he had tested positive for Covid-19. Over the weekend, he received various treatments  — supplements like vitamin D, zinc and melatonin, an experimental antibody combination, an antiviral drug and a powerful anti-inflammatory…

Un-Sheltering Tips for Your Health and Immune System

Un-Sheltering Tips for Your Health and Immune System

As we all emerge from our bubbles of limited contact with others, we are walking straight into the double whammy of flu season and COVID-19 germs. Can your body fight off exposure to the flu and COVID? Your immune system feeds off the basics of life — sleep, movement, food…